135 related articles for article (PubMed ID: 2260205)
1. Visceral leishmaniasis in Sudan. Clinical features.
Siddig M; Ghalib H; Shillington DC; Petersen EA; Khidir S
Trop Geogr Med; 1990 Apr; 42(2):107-12. PubMed ID: 2260205
[TBL] [Abstract][Full Text] [Related]
2. Visceral leishmaniasis in the Sudan: comparative parasitological methods of diagnosis.
Siddig M; Ghalib H; Shillington DC; Petersen EA
Trans R Soc Trop Med Hyg; 1988; 82(1):66-8. PubMed ID: 3176153
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic leishmaniasis--first case report from Nepal.
Sharma SK; Das ML; Rijal S; Sah SP; Koirala S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):749-50. PubMed ID: 12041549
[TBL] [Abstract][Full Text] [Related]
4. Lymphadenopathy in a child with Indian kala-azar in Dharan, Nepal.
Singh K; Singh R; Parija SC
Indian Pediatr; 1998 Nov; 35(11):1125-6. PubMed ID: 10216552
[No Abstract] [Full Text] [Related]
5. Epidemiology of visceral leishmaniasis in India.
Bora D
Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological, clinical and therapeutic features of pediatric kala-azar.
Rahim KM; Ashkan MM
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):626-30. PubMed ID: 17882998
[TBL] [Abstract][Full Text] [Related]
7. Utility of lymph node aspiration in the diagnosis of visceral leishmaniasis in Sudan.
Babiker ZO; Davidson R; Mazinda C; Kipngetich S; Ritmeijer K
Am J Trop Med Hyg; 2007 Apr; 76(4):689-93. PubMed ID: 17426171
[TBL] [Abstract][Full Text] [Related]
8. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
[TBL] [Abstract][Full Text] [Related]
9. Sudanese mucosal leishmaniasis: isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis.
Mahdi M; Elamin EM; Melville SE; Musa AM; Blackwell JM; Mukhtar MM; Elhassan AM; Ibrahim ME
Infect Genet Evol; 2005 Jan; 5(1):29-33. PubMed ID: 15567136
[TBL] [Abstract][Full Text] [Related]
10. Post kala azar dermal leishmaniasis in Sudan.
Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
[TBL] [Abstract][Full Text] [Related]
11. Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran.
Ashkan MM; Rahim KM
Trop Doct; 2008 Jul; 38(3):186-8. PubMed ID: 18628558
[TBL] [Abstract][Full Text] [Related]
12. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm.
Magill AJ; Grögl M; Gasser RA; Sun W; Oster CN
N Engl J Med; 1993 May; 328(19):1383-7. PubMed ID: 8292114
[TBL] [Abstract][Full Text] [Related]
13. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
Gravino AE
Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological study of clinically undiagnosed cases of kala-azar with special reference to grading of parasites.
Mukherjee C; Mitra PK; Dasgupta A; Ghosh RN
J Indian Med Assoc; 1995 Mar; 93(3):87-9. PubMed ID: 8522820
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of kala-azar in Bombay.
Bhatia S; Patel N; Gulhane S; Dongre V; Jijina FF; Pathare AV
J Postgrad Med; 1995; 41(1):3-4. PubMed ID: 10740690
[TBL] [Abstract][Full Text] [Related]
16. Antimony-resistant Leishmania donovaniin eastern Sudan: incidence and in vitro correlation.
Abdo MG; Elamin WM; Khalil EA; Mukhtar MM
East Mediterr Health J; 2003 Jul; 9(4):837-43. PubMed ID: 15748080
[TBL] [Abstract][Full Text] [Related]
17. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
Toran KC; Sah SP; Joshi A; Rani S
Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan.
Andresen K; Gasim S; Elhassan AM; Khalil EA; Barker DC; Theander TG; Kharazmi A
Trop Med Int Health; 1997 May; 2(5):440-4. PubMed ID: 9217699
[TBL] [Abstract][Full Text] [Related]
19. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
[TBL] [Abstract][Full Text] [Related]
20. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
